FDA director testifying on meningitis outbreak
A story in the Boston Globe says congressional representatives investigating a deadly fungal meningitis outbreak have called FDA Commissioner Dr. Margaret Hamburg to testify at a House Energy and...
View ArticleFDA warns of false meningitis cure
The U.S. Food and Drug Administration warns that a company’s claims of treating or curing fungal meningitis with “light therapy” are false. According to a story posted on the ABC News Website, The...
View ArticleProfessor: Limits on FDA caused outbreak
A Boston University law professor claims legal limitations on the U.S. Food and Drug Administration are indirectly responsible for a national meningitis outbreak that has sickened more than 400 people...
View ArticleOther pharmacies on guard after deadly outbreak
After a Massachusetts compounding pharmacy was found to be the source of a deadly meningitis outbreak, other compounding pharmacies are looking at the story as a cautionary example of what can happen...
View ArticleCompany linked with meningitis pharmacy lays off workers
Ameridose LLC, which is affiliated with the specialty pharmacy behind a deadly meningitis outbreak, is laying off about 90 percent of its workforce, according to a Reuters story. The company suspended...
View ArticleMeningitis pharmacy owner has history of noncompliance
The co-owner of the New England Compounding Center, a Massachusetts pharmacy blamed for a deadly meningitis outbreak, allegedly has a history of failing to cooperate with federal regulators. A...
View ArticleWidow of meningitis victim submits testimony
During the first of two Congressional hearings to take place this week in response to a deadly meningitis outbreak, the widow of a victim urged lawmakers to crack down on drug compounders, Reuters...
View ArticleMeningitis pharmacy owner refuses to testify
The co-owner of a specialty pharmacy responsible for a deadly meningitis outbreak refused to talk to members of a congressional panel that discussed the issue on Wednesday, according to a story in the...
View ArticleRegulators faulted over meningitis outbreak
A congressional report on the specialty pharmacy linked to a deadly meningitis outbreak has faulted state and federal regulators for failing to address serious safety concerns at the New England...
View ArticleTainted steroid may produce more infections
State and federal health officials are warning that tainted steroid medication from a Massachusetts specialty pharmacy may cause more infections, in addition to the fungal meningitis that has already...
View ArticleGroup says Medicare spurred meningitis outbreak
A consumer advocacy group has raised the possibility that Medicare policy spurred the rise of large-scale drug compounding, which is widely considered the indirect cause of a deadly meningitis...
View ArticleMeningitis outbreak prompts call for more inspections
In light of a deadly meningitis outbreak, public health watchdog group “Public Citizen” is calling on the U.S. Food and Drug Administration to re-inspect more than a dozen compounding pharmacies with...
View ArticlePatients believe outbreak wider than reported
The scope of a deadly outbreak linked to a Massachusetts pharmacy may be wider than initially thought, the U.S. Food and Drug Administration reports. And now some patients who received medications from...
View ArticleLawyers for meningitis pharmacy trying to consolidate cases
Lawyers representing the New England Compounding Center, a specialty pharmacy blamed in a deadly meningitis outbreak, are trying to consolidate a number of lawsuits filed against their client. A report...
View ArticleMore contaminants in drugs from meningitis pharmacy
The U.S. Centers for Disease Control and Prevention is warning health care providers of additional contaminants in drugs made by the New England Compounding Center – a Massachusetts specialty pharmacy...
View ArticleFDA, state officials take look at compounding pharmacies
During a conference that included public health officials from all 50 states, the U.S. Food and Drug Administration examined the role of the federal government in regulating “compounding pharmacies.” A...
View ArticleMeningitis pharmacy owners got $16 million
The owners of a specialty pharmacy blamed for a deadly fungal meningitis outbreak got more than $16 million from the business last year – which accounts for about half of its sales. The Boston Globe,...
View ArticleInspections shut down 11 Mass. pharmacies
State officials in Massachusetts have shut down 11 specialty pharmacies of the type responsible for last year’s deadly meningitis outbreak, following a series of surprise inspections. According to a...
View ArticleDeath toll rises from meningitis outbreak
The death toll continues to climb from a fungal meningitis outbreak related to a batch of contaminated steroid medication, the Boston Herald reports. Six months after health authorities first...
View ArticleAnother recall from compounding pharmacy
A Georgia compounding pharmacy called Clinical Specialties is recalling syringes of the drug Avastin, following reports that they may have caused eye infections. Compounding pharmacies prepare...
View ArticleMedPrep Consulting recalls drugs over contamination scare
The U.S. Food and Drug Administration has announced a national recall of drugs from a New Jersey compounding pharmacy called Med Prep Consulting Inc., citing concerns of possible mold contamination....
View ArticleAnother compounding pharmacy recalls products
A Massachusetts drug compounder called Pallimed Solutions has voluntarily recalled more than a dozen sterile drugs and compounds following an inspection, CNN reports. Although the company says it has...
View ArticleDoctor: Compounding pharmacy recalls not surprising
Critics of the pharmaceutical compounding industry aren’t surprised by a spate of recalls, according to a story in USA Today. Two recent recalls include a Georgia compounding pharmacy called Clinical...
View ArticleAttorney general wants criminal investigation into pharmacy
Michigan’s attorney general is calling for a criminal investigation into the New England Compounding Center – a Massachusetts-based specialty pharmacy blamed for a deadly meningitis outbreak that has...
View ArticleMeningitis pharmacy was violating law
According to a USA Today story about an ongoing fungal meningitis outbreak, the specialty pharmacy responsible has been flagrantly violating both sanitation standards and the terms of the federal laws...
View ArticleGrand jury investigating meningitis pharmacy
According to a report on Michigan Live, the Michigan Court of Appeals is allowing state Attorney General Bill Schuette to empanel a multi-district grand jury, tasked with investigating the specialty...
View ArticleFDA chief says more authority needed on compounders
Food and Drug Administration Commissioner Dr. Margaret A. Hamburg has admitted that her agency wasn’t aggressive enough in investigating compounding pharmacies, such as the one responsible for a...
View ArticleInspection prompts medicine recalls
Following an inspection by the U.S. Food and Drug Administration, a Florida specialty pharmacy called The Compounding Shop is recalling all of its sterile products, ABC News reports. According to the...
View ArticleFungal meningitis presents danger of relapse
A deadly fungal meningitis outbreak apparently caused by tainted medication may present yet another hazard for patients, according to a NBC News story. Officials with the U.S. Centers for Disease...
View ArticleSenate compounding pharmacy bill criticized as too soft
A U.S. Senate committee has approved a bill designed to impose tighter restrictions on compounding pharmacies, such as the one blamed for a deadly meningitis outbreak. The legislation is now headed for...
View Article
